RhythmAnalytics vs Eko Analysis Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Biofourmis Singapore Pte.
VS
by Eko Devices

AI Verdict

RhythmAnalytics specializes in comprehensive, automated interpretation of various cardiac arrhythmias from single-lead ECG data, ideal for integrating into existing monitoring systems. Eko Analysis Software, conversely, integrates with digital stethoscopes to aid in the early detection of heart murmurs and atrial fibrillation, offering a more front-line diagnostic tool. While both leverage AI for cardiac condition detection and share AFib detection capabilities, their primary input methods and specific feature sets cater to different clinical workflows.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is automated, comprehensive interpretation of a wide range of cardiac arrhythmias from diverse single-lead ECG data sources. This cloud-based API solution is ideal for healthcare systems or integrators seeking to enhance clinical decision support with detailed, AI-powered ECG analysis from Holter monitors, event recorders, or wearable sensors.

View RhythmAnalytics →

Choose Eko Analysis Software if…

Choose Eko Analysis Software if you are a clinician utilizing Eko's digital stethoscopes and require an integrated solution for real-time auscultation and AI-powered screening for heart murmurs and atrial fibrillation. This tool is best suited for point-of-care assessments, allowing for immediate recording, playback, and visualization of heart sounds and ECGs directly within a mobile app environment.

View Eko Analysis Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RhythmAnalytics Eko Analysis Software
Pricing Contact vendor Freemium with subscription for full features
Deployment Cloud-based API Cloud-based
FDA Status 1 AI-estimated 1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Analysis Software

Tool B offers a more direct and integrated user experience for clinicians through its dedicated digital stethoscopes and mobile application, including clear user manuals and troubleshooting guides. Tool A, primarily an API, relies on third-party integration for its end-user interface, making its direct usability less apparent for a clinician.

Clinical Value

Eko Analysis Software

Both tools offer significant clinical value with FDA clearances. Tool A provides comprehensive arrhythmia detection from ECG data, covering over 15 types. However, Tool B uniquely integrates AI with digital stethoscopes for point-of-care detection of heart murmurs (including timing and severity across all ages), atrial fibrillation, and low ejection fraction, offering a broader diagnostic scope for cardiovascular assessment.

Pricing & Value

Eko Analysis Software

Tool B clearly wins in pricing transparency and value, offering a freemium model with detailed subscription tiers for its full features. This allows users to explore basic functionalities for free. Tool A's 'contact vendor' pricing lacks transparency and immediate value proposition.

Enterprise Readiness

Eko Analysis Software

Tool B explicitly states it has Business Associate Agreements (BAA) and is SOC 2 certified, which are critical for enterprise adoption and data security in healthcare. It also provides dedicated resources for enterprise customers. While Tool A is designed for integration and used by major institutions, the BAA status for RhythmAnalytics itself is unspecified in the provided data, posing a potential hurdle for enterprise clients.

Innovation

Eko Analysis Software

Both tools are highly innovative. Tool A's innovation lies in its deep learning for comprehensive and highly accurate arrhythmia detection from ECG, outperforming other systems and cardiologists in some metrics. Tool B's innovation is in integrating AI with a physical digital stethoscope for real-time, point-of-care detection of multiple cardiovascular conditions (murmurs, AFib, low ejection fraction), including the 'first FDA-cleared foundation model for cardiovascular AI,' offering a more integrated and novel approach to diverse point-of-care diagnostics.

Support & Docs

Eko Analysis Software

Tool B provides more accessible and comprehensive support and documentation for both individual users and enterprise customers through its dedicated Eko Help Center, offering user manuals, troubleshooting guides, FAQs, and direct support contact options. Tool A's support and documentation for RhythmAnalytics as a standalone product are not readily apparent for end-users, leaning more towards integrator documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RhythmAnalytics Eko Analysis Software
Name RhythmAnalytics Eko Analysis Software
Company Biofourmis Singapore Pte. Eko Devices
Description FDA-cleared, AI-powered cloud-based software that provides automated interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support for healthcare professionals and integrators. FDA-cleared AI-powered tool that integrates with Eko's digital stethoscopes and mobile app to assist clinicians in the early detection of cardiovascular diseases like heart murmurs and atrial fibrillation.
Key AI Detections Over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats) Heart murmur detection, Atrial Fibrillation (AFib) detection, normal sinus rhythm

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and Eko Analysis Software.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

RhythmAnalytics is designed for automated interpretation of over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, and ectopic beats. Eko Analysis Software focuses on the early detection of heart murmurs and atrial fibrillation (AFib), in addition to identifying normal sinus rhythm.
RhythmAnalytics processes single-lead ECG data from various compatible FDA-cleared ECG devices like Holter monitors, event recorders, and wearable sensors. Eko Analysis Software integrates with Eko's own digital stethoscopes and mobile app to analyze heart sounds (phonocardiograms) and ECG tracings.
RhythmAnalytics is offered as a cloud-based API, suggesting it can be integrated into existing healthcare systems that collect ECG data for automated analysis. Eko Analysis Software works in conjunction with Eko's digital stethoscopes and mobile app, providing features like recording, playback, annotation, and secure cloud storage of heart sounds and ECGs.
RhythmAnalytics provides AI-based automated interpretation of cardiac arrhythmias, including beat-by-beat morphology computation and QRS feature extraction from ECG data. Eko Analysis Software features FDA-cleared AI for detecting heart murmurs and atrial fibrillation, along with calculating cardiac time intervals from auscultation and ECG data.
RhythmAnalytics is compatible with various FDA-cleared ECG devices, such as Holter monitors, event recorders, and wearable sensors, providing flexibility in data input. Eko Analysis Software is designed to integrate specifically with Eko's own line of digital stethoscopes and its accompanying mobile application.

Backers

Who funded each tool's parent company.

Eko Analysis Software

AI Tool Finder
AI-powered search. Results may not be comprehensive.